Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A case for Bayesianism in clinical trials

D A Berry1

  • 1Institute of Statistics and Decision Sciences, Duke University, Durham, NC 27708-0251.

Statistics in Medicine
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

Breast cancer research and treatment·2016
Same author

Emerging innovations in clinical trial design.

Clinical pharmacology and therapeutics·2015
Same author

The Signature Program: Bringing the Protocol to the Patient.

Clinical pharmacology and therapeutics·2015
Same author

CYP2D6 genotype and adjuvant tamoxifen.

Clinical pharmacology and therapeutics·2014
Same author

Assessment of local vocal fold deformation characteristics in an in vitro static tensile test.

The Journal of the Acoustical Society of America·2011
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
See all related articles

This study compares Bayesian and frequentist approaches for clinical trial design and analysis. The Bayesian method offers greater flexibility in data analysis and decision-making, making it ideal for clinical research.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Medical Research

Background:

  • Clinical trials involve learning under uncertainty.
  • Both Bayesian and frequentist approaches address this, but differ significantly.
  • Frequentist measures are design-dependent, requiring pre-planned interim analyses.

Purpose of the Study:

  • To compare Bayesian and frequentist approaches in clinical trial design and analysis.
  • To highlight the flexibility and advantages of the Bayesian approach.
  • To discuss differences in decision-making and the role of randomization.

Main Methods:

  • The paper describes a Bayesian approach to clinical trial design and analysis.
  • It contrasts this with the traditional frequentist methodology.

Related Experiment Videos

  • Key differences in data handling, interim analyses, and decision-making are discussed.

    • Main Results:

    • The Bayesian approach allows for flexible updating of measures as new data accrues.
    • It enables combining information from various sources for robust conclusions.
    • Bayesian methods facilitate predictive probability calculations for future observations.

    Conclusions:

    • The Bayesian approach is more flexible and adaptable for clinical trial data analysis.
    • Its ability to integrate diverse information sources enhances inference.
    • Bayesian methodology offers distinct advantages in clinical trial design and decision-making, including a different perspective on randomization.